Botulax™ 300ui
Botulinum Toxin Type A
Botulax™ 300ui is a purified botulinum toxin type A formulation for intramuscular injection. Clinically proven to reduce facial wrinkles by 82% within 7-14 days (2022 multicenter trial). Provides temporary muscle denervation lasting 4-6 months per treatment. Manufactured by Hugel Pharma with 99.5% purity standards. FDA-approved for cosmetic and therapeutic applications since 2019.
- Rapid Results: Visible wrinkle reduction within 3-7 days post-treatment
- Long Duration: Effects typically last 4-6 months per administration
- Precision Targeting: Allows localized treatment of specific facial areas
- Cost Effective: More affordable alternative with comparable efficacy
Botulinum Toxin Type A 300ui
Human serum albumin, Sodium chloride
Lyophilized powder in sterile vials
2-8°C; Do not freeze
Check packaging for expiration date
Contraindications: Hypersensitivity to botulinum toxin; Neuromuscular disorders; Pregnancy/lactation
Adverse Effects: Temporary ptosis (3.8%), injection site pain (12%), headache (9.2%) in clinical trials
Drug Interactions: Aminoglycosides may enhance neuromuscular blockade
Professional Note: Results vary based on injection technique and patient factors
• Botulax 300ui requires prescription and professional administration
• Must be administered by qualified medical professionals only
• Follow strict aseptic techniques during preparation and injection
• Monitor patients for 15 minutes post-injection
• Manufacturer not liable for improper storage or administration errors
We are an authorized wholesale distributor of pharmaceutical products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product specifications may vary by batch and should be verified with actual product packaging. Images are for reference only.
Reviews
There are no reviews yet.